LSAMP and cancer: There are various mechanisms of LSAMP downregulation in several cancers, by genomic rearrangements, most frequently deletions, epigenetic silencing, or potentially post-transcriptional or post-translational inactivation, each of which may be related to predisposition to disease progression.